News

The ALS Therapy Development Institute's scientists aim to discover and prioritize the most promising strategies to slow, stop, and reverse amyotrophic lateral sclerosis (ALS) disease progression. The Research Biology team dissects ALS pathology using broad genome-wide profiling technologies (trillions of data-points) integrated with high resolution studies of single proteins within single cells.